Pen-type injector

Information

  • Patent Grant
  • 11160928
  • Patent Number
    11,160,928
  • Date Filed
    Monday, August 21, 2017
    6 years ago
  • Date Issued
    Tuesday, November 2, 2021
    2 years ago
Abstract
The present invention relates to injectors, such as pen-type injectors, that provide for administration of medicinal products from a multidose-cartridge and permit a user to set the delivery dose. The injector may include a housing, a piston rod adapted to operate through the housing, a dose dial sleeve located between the housing and the piston rod, and a drive sleeve located between the dose dial sleeve and the piston rod. The dose dial sleeve may have a helical thread of first lead and the drive sleeve may have a helical groove of second lead. The first lead of the helical thread and the second lead of the helical groove may be the same.
Description
BACKGROUND

The present invention relates to pen-type injectors, that is, to injectors of the kind that provide for administration by injection of medicinal products from a multidose cartridge. In particular, the present invention relates to such injectors where a user may set the dose.


Such injectors have application where regular injection by persons without formal medical training occurs. This is increasingly common amongst those having diabetes where self-treatment enables such persons to conduct effective management of their diabetes.


These circumstances set a number of requirements for pen-type injectors of this kind. The injector must be robust in construction, yet easy to use both in terms of the manipulation of the parts and understanding by a user of its operation. In the case of those with diabetes, many users will be physically infirm and may also have impaired vision. Where the injector is to be disposable rather than reusable, the injector should be cheap to manufacture and easy to dispose of (preferably being suitable for recycling).


SUMMARY

It is an advantage of the present invention that an improved pen-type injector is provided.


According to a first aspect of the present invention, a pen-type injector comprises


a housing;


a piston rod adapted to operate through housing;


a dose dial sleeve located between the housing and the piston rod, the dose dial sleeve having a helical thread of first lead;


a drive sleeve located between the dose dial sleeve and the piston rod, the drive sleeve having a helical groove of second lead;


characterized in that the first lead of the helical thread and the second lead of the helical groove are the same.


Preferably, the piston rod has a first threaded portion at a first end and a second threaded portion at a second end;


an insert or radially inwardly extending flange is located in the housing and through which the first threaded portion of the piston rod may rotate;


the dose dial sleeve being rotatable with respect to the housing and the insert;


the drive sleeve being releasably connected to the dose dial sleeve and connected to the piston rod for rotation with respect thereto along the second threaded portion of the piston rod;


a button is located on the dose dial sleeve and rotatable with respect to the does dial sleeve; and


clutch means are provided which upon depression of the button permit rotation between the dose dial sleeve and the drive sleeve.


Preferably, the injector further comprises a nut which is rotatable with respect to the drive sleeve and axially displaceable but not rotatable with respect to the housing.


More preferably, the drive sleeve is provided at a first end with first and second flanges with an intermediate thread between the first and second flanges, the nut being disposed between the first and second flanges and keyed to the housing by spline means. Additionally, a first radial stop may be provided on a second face of the nut and a second radial stop may be provided on a first face of the second flange.


Preferably, the first thread of the piston rod is oppositely disposed to the second thread of the piston rod.


Preferably, a second end of the clutch is provided with a plurality of dog teeth adapted to engage with a second end of the dose dial sleeve.


Preferably, the pen-type injector further includes clicker means disposed between the clutch means and spline means provided on the housing.


More preferably, the clicker means comprises a sleeve provided at a first end with a helically extending arm, a free end of the arm having a toothed member, and at a second end with a plurality of circumferentially directed saw teeth adapted to engage a corresponding plurality of circumferentially saw teeth provided on the clutch means.


Alternatively, the clicker means comprises a sleeve provided at a first end with at least one helically extending arm and at least one spring member, a free end of the arm having a toothed member, and at a second end with a plurality of circumferentially directed saw teeth adapted to engage a corresponding plurality of circumferentially directed saw teeth provided on the clutch means.


Preferably, the main housing is provided with a plurality of maximum dose stops adapted to be abutted by a radial stop provided on the dose dial sleeve. More preferably, at least one of the maximum dose stops comprises a radial stop located between a helical rib and spline means provided at a second end of the housing. Alternatively, at least one of the maximum dose stops comprises a part of a raised window portion provided at a second end of the housing.


Preferably, the dose dial sleeve is provided with a plurality of radially extending members adapted to abut a corresponding plurality of radial stops provided at a second end of the housing.





BRIEF DESCRIPTION OF THE FIGURES

The invention will now be described with reference to the accompanying drawings in which:



FIG. 1 shows a sectional view of a pen-type injector in accordance with the present invention in a first, cartridge full, position;



FIG. 2 shows a sectional view of the pen-type injector of FIG. 1 in a second, maximum first dose dialed, position;



FIG. 3 shows a sectional view of the pen-type injector of FIG. 1 in a third, first maximum first dose dispensed, position;



FIG. 4 shows a sectional view of the pen-type injector of FIG. 1 in a fourth, final dose dialed, position;



FIG. 5 shows a sectional view of the pen-type injector of FIG. 1 in a fifth, final dose dispensed, position;



FIG. 6 shows a cut-away view of a first detail of the pen-type injector of FIG. 1;



FIG. 7 shows a partially cut-away view of a second detail of the pen-type injector of FIG. 1;



FIG. 8 shows a partially cut-away view of a third detail of the pen-type injector of FIG. 1;



FIG. 9 shows the relative movement of parts of the pen-type injector shown in FIG. 1 during dialing up of a dose;



FIG. 10 shows the relative movement of parts of the pen-type injector shown in FIG. 1 during dialing down of a dose;



FIG. 11 shows the relative movement of parts of the pen-type injector shown in FIG. 1 during dispensing of a dose;



FIG. 12 shows a partially cut-away view of the pen-type injector of FIG. 1 in the second, maximum first dose dialed, position;



FIG. 13 shows a partially cut-away view of the pen-type injector of FIG. 1 in the fourth, final dose dialed, position;



FIG. 14 shows a partially cut-away view of the pen-type injector of FIG. 1 in one of the first, third or fifth positions;



FIG. 15 shows a cut-away view of a first part of a main housing of the pen-type injector of FIG. 1; and



FIG. 16 shows a cut-away view of a second part of the main housing of the pen-type injector of FIG. 1.





DETAILED DESCRIPTION

Referring first to FIGS. 1 to 5, there may be seen a pen-type injector in accordance with the present invention in a number of positions.


The pen-type injector comprises a housing having a first cartridge retaining part 2, and second main housing part 4. A first end of the cartridge retaining means 2 and a second end of the main housing 4 are secured together by retaining features 6. In the illustrated embodiment, the cartridge retaining means 2 is secured within the second end of the main housing 4.


A cartridge 8 from which a number of doses of medicinal product may be dispensed is provided in the cartridge retaining part 2. A piston 10 is retained in a first end of the cartridge 8.


A removable cap 12 is releasably retained over a second end of the cartridge retaining part 2. In use the removable cap 12 can be replaced by a user with a suitable needle unit (not shown). A replaceable cap 14 is used to cover the cartridge retaining part 2 extending from the main housing 4. Preferably, the outer dimensions of the replaceable cap 14 are similar or identical to the outer dimensions of the main housing 4 to provide the impression of a unitary whole when the replaceable cap 14 is in position covering the cartridge retaining part 2.


In the illustrated embodiment, an insert 16 is provided at a first end of the main housing 4. The insert 16 is secured against rotational or longitudinal motion. The insert 16 is provided with a threaded circular opening 18 extending therethrough. Alternatively, the insert may be formed integrally with the main housing 4 the form of a radially inwardly directed flange having an internal thread.


A first thread 19 extends from a first end of a piston rod 20. The piston rod 20 is of generally circular section. The first end of the piston rod 20 extends through the threaded opening 18 in the insert 16. A pressure foot 22 is located at the first end of the piston rod 20. The pressure foot 22 is disposed to abut a second end of the cartridge piston 10. A second thread 24 extends from a second end of the piston rod 20. In the illustrated embodiment the second thread 24 comprises a series of part threads rather than a complete thread. The illustrated embodiment is easier to manufacture and helps reduce the overall force required for a user to cause medicinal product to be dispensed.


The first thread 19 and the second thread 24 are oppositely disposed. The second end of the piston rod 20 is provided with a receiving recess 26.


A drive sleeve 30 extends about the piston rod 20. The drive sleeve 30 is generally cylindrical. The drive sleeve 30 is provided at a first end with a first radially extending flange 32. A second radially extending flange 34 is provided spaced a distance along the drive sleeve 30 from the first flange 32. An intermediate thread 36 is provided on an outer part of the drive sleeve 30 extending between the first flange 32 and the second flange 34. A helical groove 38 extends along the internal surface of the drive sleeve 30. The second thread 24 of the piston rod 20 is adapted to work within the helical groove 38.


A first end of the first flange 32 is adapted to conform to a second side of the insert 16.


A nut 40 is located between the drive sleeve 30 and the main housing 2, disposed between the first flange 32 and the second flange 34. In the illustrated embodiment the nut 40 is a half-nut. This assists in the assembly of the injector. The nut 40 has an internal thread matching the intermediate thread 36. The outer surface of the nut 40 and an internal surface of the main housing 4 are keyed together by splines 42 (see FIGS. 10, 11, 15 and 16) to prevent relative rotation between the nut 40 and the main housing 4, while allowing relative longitudinal movement therebetween.


A shoulder 37 is formed between a second end of the drive sleeve 30 and an extension 38 provided at the second end of the drive sleeve 30. The extension 38 has reduced inner and outer diameters in comparison to the remainder of the drive sleeve 30. A second end of the extension 38 is provided with a radially outwardly directed flange 39.


A clicker 50 and a clutch 60 are disposed about the drive sleeve 30, between the drive sleeve 30 and a dose dial sleeve 70 (to be described below).


The clicker 50 is located adjacent the second flange 34 of the drive sleeve 30. The clicker 50 is generally cylindrical and is provided at a first end with a flexible helically extending arm 52 (shown most clearly in FIG. 6). A free end of the arm 52 is provided with a radially directed toothed member 54. A second end of the clicker 50 is provided with a series of circumferentially directed saw teeth 56 (of FIG. 7). Each saw tooth comprises a longitudinally directed surface and an inclined surface.


In an alternative embodiment (not shown) the clicker means further includes at least one spring member. The at least one spring member assists in the resetting of the clutch means 60 following dispense.


The clutch means 60 is located adjacent the second end of the drive sleeve 30. The clutch means 60 is generally cylindrical and is provided at a first end with a series of circumferentially directed saw teeth 66 (see FIG. 7). Each saw tooth comprises a longitudinally directed surface and an inclined surface. Towards the second end 64 of the clutch means 60 there is located a radially inwardly directed flange 62. The flange 62 of the clutch means 60 is disposed between the shoulder 37 of the drive sleeve 30 and the radially outwardly directed flange 39 of the extension 38. The second end of the clutch means 60 is provided with a plurality of dog teeth 65 (FIG. 8). The clutch 60 is keyed to the drive sleeve 30 by way of splines (not shown) to prevent relative rotation between the clutch 60 and the drive sleeve 30.


In the illustrated embodiment, the clicker 50 and the clutch 60 each extend approximately half the length of the drive sleeve 30. However, it will be understood that other arrangements regarding the relative lengths of these parts are possible.


The clicker 50 and the clutch means 60 are normally engaged, that is as shown in FIG. 7.


A dose dial sleeve 70 is provided outside of the clicker 50 and clutch means 60 and radially inward of the main housing 4. A helical groove 74 is provided about an outer surface of the dose dial sleeve 70.


The main housing 4 is provided with a window 44 through which a part of the outer surface of the dose dial sleeve may be seen. The main housing 4 is further provided with a helical rib 46, adapted to be seated in the helical groove 74 on the outer surface of the dose dial sleeve 70. The helical rib 46 extends for a single sweep of the inner surface of the main housing 4. A first stop 100 is provided between the splines 42 and the helical rib 46 (FIG. 15). A second stop 102, disposed at an angle of 180° to the first stop 100 is formed by a frame surrounding the window 44 in the main housing 4 (FIG. 16).


Conveniently, a visual indication of the dose that may be dialed, for example reference numerals (not shown). is provided on the outer surface of the dose dial sleeve 70. The Window 44 conveniently only allows to be viewed a visual indication of the dose currently dialed.


A second end of the dose dial sleeve 70 is provided with an inwardly directed flange in the form of number of radially extending members 75. A dose dial grip 76 is disposed about an outer surface of the second end of the dose dial sleeve 70. An outer diameter of the dose dial grip 76 preferably corresponds to the outer diameter of the main housing 4. The dose dial grip 76 is secured to the dose dial sleeve 70 to prevent relative movement therebetween. The dose dial grip 76 is provided with a central opening 78. An annular recess 80 located in the second end of the dose dial grip 76 extends around the opening 78.


A button 82 of generally ‘T’ section is provided at a second end of the pen-type injector. A stem 84 of the button 82 may extend through the opening 78 in the dose dial grip 76, through the inner diameter of the extension 38 of the drive sleeve 30 and into the receiving recess 26 of the piston rod 20. The stem 84 is retained for limited axial movement in the drive sleeve 30 and against rotation with respect thereto. A head 85 of the button 82 is generally circular. A skirt 86 depends from a periphery of the head 85. The skirt 86 is adapted to be seated in the annular recess 80 of the dose dial grip 76.


Operation of the pen-type injector in accordance with the present invention will now be described. In FIGS. 9, 10 and 11 arrows A, B. C, D, E, F and G represent the respective movements of the button 82, the dose dial grip 76, the dose dial sleeve 70, the drive sleeve 30, the clutch means 60, the clicker 50 and the nut 40.


To dial a dose (FIG. 9) a user rotates the dose dial grip 76 (arrow A). With the clicker 50 and clutch means 60 engaged, the drive sleeve 30, the clicker 50, the clutch means 60 and the dose dial sleeve 70 rotate with the dose dial grip 76.


Audible and tactile feedback of the dose being dialed is provided by the clicker 50 and the clutch means 60. Torque is transmitted through the saw teeth 56, 66 between the clicker 50 and the clutch means 60. The flexible arm 52 deforms and drags the toothed member 54 over the splines 42 to produce a click. Preferably, the splines 42 are dispose such that each click corresponds to a unit dose.


The helical groove 74 on the dose dial sleeve 70 and the helical groove 38 in the drive sleeve 30 have the same lead. This allows the dose dial sleeve 70 (arrow C) to extend from the main housing 4 and the drive sleeve 30 (arrow D) to climb the piston rod 20 at the same rate. At the limit of travel, a radial stop 104 on the dose dial sleeve 70 engages either the first stop 100 or the second stop 102 provided on the main housing 4 to prevent further movement. Rotation of the piston rod 20 is prevented due to the opposing directions of the overhauled and driven threads on the piston rod 20.


The nut 40, keyed to the main housing 4, is advanced along the intermediate thread 36 by the rotation of the drive sleeve 30 (arrow D). When the final dose dispensed position (FIGS. 4, 5 and 13) is reached, a radial stop 106 formed on a second surface of the nut 40 abuts a radial stop 108 on a first surface of the second flange 34 of the drive sleeve 30 preventing both the nut 40 and the drive sleeve 30 from rotating further.


In an alternative embodiment (not shown) a first surface of the nut 40 is provided with a radial stop for abutment with a radial stop provided on a second surface of the first flange 32. This aids location of the nut 40 at the cartridge full position during assembly of the pen-type injector.


Should a user inadvertently dial beyond the desired dosage, the pen-type injector allows the dosage to be dialed down without dispense of medicinal product from the cartridge (FIG. 10). The dose dial grip 76 is counter rotated. This causes the system to act in reverse. The flexible arm 52 now acts as a ratchet preventing the clicker from rotating. The torque transmitted through the clutch means 60 causes the saw teeth 56,66 to ride over one another to create the clicks corresponding to dialed dose reduction. Preferably the saw teeth 56,66 are so disposed that the circumferential extent of each saw tooth corresponds to a unit dose.


When the desired dose has been dialed, the user may then dispense this dose by depressing the button 82 (FIG. 11). This displaces the clutch means 60 axially with respect to the dose dial sleeve 70 causing the dog teeth 65 to disengage. However the clutch means 60 remains keyed in rotation to the drive sleeve 30. The dose dial sleeve 70 and associated dose dial grip 76 are now free to rotate (guided by the helical rib 46 located in helical groove 74).


The axial movement deforms the flexible arm 52 of the clicker 50 to ensure the saw teeth 56,66 cannot be overhauled during dispense. This prevents the drive sleeve 30 from rotating with respect to the main housing 4 though it is still free to move axially with respect thereto. This deformation is subsequently used to urge the clicker 50, and the clutch 60, back along the drive sleeve 30 to restore the connection between the clutch 60 and the dose dial sleeve 70 when pressure is removed from the button 82.


The longitudinal axial movement of the drive sleeve 30 causes the piston rod 20 to rotate though the opening 18 in the insert 16, thereby to advance the piston 10 in the cartridge 8. Once the dialed dose has been dispensed, the dose dial sleeve 70 is prevented from further rotation by contact of a plurality of members 110 (FIG. 14) extending from the dose dial grip 76 with a corresponding plurality of stops 112 formed in the main housing 4 (FIGS. 15 and 16). In the illustrated embodiment, the members 110 extend axially from the dose dial grip 76 and have an inclined end surface. The zero dose position is determined by the abutment of one of the axially extending edges of the members 110 with a corresponding stop 112.

Claims
  • 1. A method of providing an injection device, comprising the steps of: adapting a piston rod to operate through a housing;locating a dose dial sleeve between the housing and the piston rod, the dose dial sleeve having a helical thread of a first lead; andlocating a drive sleeve between the dose dial sleeve and the piston rod, the drive sleeve having a helical groove of a second lead;wherein the first lead of the helical thread and the second lead of the helical groove are the same,wherein the dose dial sleeve and the drive sleeve are not mechanically engaged by the helical thread of the dose dial sleeve and the helical groove of the drive sleeve.
  • 2. The method of claim 1, further comprising the step of: releasably connecting the drive sleeve and the dose dial sleeve.
  • 3. The method of claim 1, further comprising the steps of: providing the piston rod with a first threaded portion at a first end; andproviding the piston rod with a second threaded portion at a second end.
  • 4. The method of claim 3, further comprising the steps of: locating an insert in the housing and through which the first threaded portion of the piston rod may rotate;wherein the dose dial sleeve is rotatable with respect to the housing and the insert.
  • 5. The method of claim 4, further comprising the step of: releasably connecting the drive sleeve to the dose dial sleeve.
  • 6. The method of claim 3, further comprising the step of: connecting the drive sleeve to the piston rod for rotation with respect thereto along the second threaded portion of the piston rod.
  • 7. The method of claim 3, further comprising the step of: oppositely disposing the first thread of the piston rod to the second thread of the piston rod.
  • 8. The method of claim 1, further comprising the step of: locating a button on the dose dial sleeve and rotatable with respect to the dose dial sleeve.
  • 9. The method of claim 8, further comprising the step of: providing a clutch which upon depression of the button permits rotation between the dose dial sleeve and the drive sleeve.
  • 10. The method of claim 9, further comprising the step of: providing a second end of the clutch with a plurality of dog teeth.
  • 11. The method of claim 10, further comprising the step of: adapting the plurality of dog teeth to engage a second end of the dose dial sleeve.
  • 12. The method of claim 10, further comprising the step of: providing a dose dial stop on the dose dial sleeve.
  • 13. The method of claim 1, further comprising the step of: providing a nut which is rotatable with respect to the drive sleeve and axially displaceable.
  • 14. The method of claim 13, further comprising the step of: providing the drive sleeve at a first end with a first flange, andproviding the drive sleeve at a second end with a second flange.
  • 15. The method of claim 14, further comprising the step of: providing an intermediate thread between the first flange and the second flange of the drive sleeve.
  • 16. The method of claim 15, further comprising the step of: disposing a nut on the intermediate thread between the first and second flanges of the drive sleeve.
  • 17. The method of claim 16, further comprising the step of: keying the nut to the housing.
  • 18. The method of claim 16, further comprising the step of: providing a first radial stop on a second face of the nut, andproviding a second radial stop on a first face of the second flange.
  • 19. The method of claim 1, further comprising the step of; providing the housing with a maximum dose stop.
  • 20. The method of claim 19, further comprising the step of: adapting the maximum dose stop to be abutted by a radial stop provided on the dose dial sleeve.
  • 21. A method comprising: disposing a dose dial sleeve radially inward from a housing comprising a thread, a dose dispensing end, and a zero dose stop member that is integral to the housing, the zero dose stop member protruding radially inward and having a surface that forms a radial stop, the dose dial sleeve comprising a thread that engages with the thread of the housing;disposing a clutch radially inward from the dose dial sleeve;engaging the dose dial sleeve with the radial stop of the zero dose stop member to prevent the dose dial sleeve from rotating in a dialing down direction past an end position; androtationally fixing the clutch to the dose dial sleeve during dose setting, a button configured to be depressed axially toward the dose dispensing end of the housing, the piston rod configured to axially traverse through the housing during dose dispensing in response to the button being depressed axially toward the dose dispensing end of the housing.
  • 22. A method of providing an injection device, comprising the steps of: adapting a piston rod to operate through a housing;locating a dose dial sleeve between the housing and the piston rod, the dose dial sleeve comprising a helical thread of a first lead;engaging the helical thread of the dose dial sleeve with a thread of the housing;locating a drive sleeve between the dose dial sleeve and the piston rod, the drive sleeve comprising a helical groove of a second lead, wherein the first lead of the helical thread and the second lead of the helical groove are the same, and the dose dial sleeve and the drive sleeve are not mechanically engaged by the helical thread of the dose dial sleeve and the helical groove of the drive sleeve; andengaging the helical groove of the drive sleeve with the piston.
Priority Claims (1)
Number Date Country Kind
0304822 Mar 2003 GB national
CROSS REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of U.S. patent application Ser. No. 15/180,141, filed Jun. 13, 2016, now U.S. Pat. No. 9,775,954, which is a continuation of U.S. patent application Ser. No. 14/946,203, filed Nov. 19, 2015, now U.S. Pat. No. 9,408,979, which is a continuation of U.S. patent application Ser. No. 14/635,573, filed Mar. 2, 2015, now U.S. Pat. No. 9,233,211, which is a continuation of U.S. patent application Ser. No. 13/919,251, filed Jun. 17, 2013, now U.S. Pat. No. 9,011,391, which is a divisional of U.S. patent application Ser. No. 13/040,198, filed Mar. 3, 2011, now U.S. Pat. No. 8,512,297, which is a continuation of U.S. patent application Ser. No. 11/483,546, filed Jul. 11, 2006, now U.S. Pat. No. 7,918,833, which is a continuation of U.S. patent application Ser. No. 10/790,225, filed Mar. 2, 2004, which claims priority to GB 0304822.0 filed Mar. 3, 2003, the entire contents of which are incorporated herein by reference.

US Referenced Citations (295)
Number Name Date Kind
186463 Dickinson Jan 1877 A
533575 Wilkens Feb 1895 A
2444570 Lawrence Jul 1948 A
2454583 Robert Nov 1948 A
2717597 Hein, Jr. Sep 1955 A
2722931 May Nov 1955 A
3021345 Waddington-Feather et al. Feb 1962 A
3815785 Gilmont Jun 1974 A
4048960 Bamidge et al. Sep 1977 A
4083288 Williams Apr 1978 A
4231325 Parks Nov 1980 A
4470317 Sabloewski et al. Sep 1984 A
4498904 Turner et al. Feb 1985 A
4568335 Updike et al. Feb 1986 A
4585439 Michel Apr 1986 A
4592745 Rex et al. Jun 1986 A
4592754 Gupte et al. Jun 1986 A
4833379 Kaibel et al. May 1989 A
4863072 Perler Sep 1989 A
4865591 Sams Sep 1989 A
4883472 Michel Nov 1989 A
4919596 Slate et al. Apr 1990 A
4936833 Sams Jun 1990 A
4973318 Holm et al. Nov 1990 A
4994033 Shockey et al. Feb 1991 A
5000650 Brewer et al. Mar 1991 A
5019190 Simon et al. May 1991 A
5030209 Wanderer et al. Jul 1991 A
5042977 Bechtold et al. Aug 1991 A
5058346 Speath Oct 1991 A
5092842 Bechtold et al. Mar 1992 A
5112317 Michel May 1992 A
5207752 Sorenson et al. May 1993 A
5226895 Harris Jul 1993 A
5226896 Harris Jul 1993 A
5246417 Haak et al. Sep 1993 A
5257987 Athayde et al. Nov 1993 A
5271527 Haber et al. Dec 1993 A
5279585 Balkwill Jan 1994 A
5279586 Balkwill Jan 1994 A
5281198 Haber et al. Jan 1994 A
5284480 Porter et al. Feb 1994 A
5304152 Sams Apr 1994 A
5308340 Harris May 1994 A
5314412 Rex May 1994 A
5318540 Athayde et al. Jun 1994 A
5320609 Haber et al. Jun 1994 A
5328486 Woodruff Jul 1994 A
5331954 Rex et al. Jul 1994 A
5370629 Michel et al. Dec 1994 A
5376081 Sapienza Dec 1994 A
5378233 Haber et al. Jan 1995 A
5380297 Wadman et al. Jan 1995 A
5383865 Michel Jan 1995 A
5391157 Harris et al. Feb 1995 A
5440976 Giuliano et al. Aug 1995 A
5445606 Haak et al. Aug 1995 A
5447150 Bacon Sep 1995 A
5478316 Bitdinger et al. Dec 1995 A
5478324 Meyer Dec 1995 A
5480387 Gabriel et al. Jan 1996 A
5492534 Athayde et al. Feb 1996 A
5503628 Fetters et al. Apr 1996 A
5505704 Pawelka et al. Apr 1996 A
5514097 Knauer May 1996 A
5545147 Harris Aug 1996 A
5546932 Galli Aug 1996 A
5547131 Brace Aug 1996 A
5549574 Townsend Aug 1996 A
5549575 Giambattista et al. Aug 1996 A
5562047 Forney et al. Oct 1996 A
5582598 Chanoch Dec 1996 A
5584815 Pawelka et al. Dec 1996 A
5591135 Gabriel Jan 1997 A
5591136 Gabriel Jan 1997 A
5599314 Neill Feb 1997 A
5611783 Mikkelsen Mar 1997 A
5626566 Peterson et al. May 1997 A
5634300 Huebner et al. Jun 1997 A
5645052 Kersey Jul 1997 A
5674204 Chanoch Oct 1997 A
5679111 Hjertman et al. Oct 1997 A
5681285 Ford et al. Oct 1997 A
5685864 Shanley et al. Nov 1997 A
5688251 Chanoch Nov 1997 A
5692640 Caulfield et al. Dec 1997 A
5693027 Hansen et al. Dec 1997 A
5709662 Olive et al. Jan 1998 A
5716990 Bagshawe et al. Feb 1998 A
5725508 Chanoch et al. Mar 1998 A
5728074 Castellano et al. Mar 1998 A
5728075 Levander Mar 1998 A
5743889 Sams Apr 1998 A
5755692 Maincom May 1998 A
5807346 Frezza Sep 1998 A
5820602 Kovelman et al. Oct 1998 A
5823998 Yamagata Oct 1998 A
5827232 Chanoch et al. Oct 1998 A
5843036 Olive et al. Dec 1998 A
5851079 Horstman et al. Dec 1998 A
5882598 Lindquist et al. Mar 1999 A
5882718 Pommer et al. Mar 1999 A
5898028 Jensen et al. Apr 1999 A
5921966 Bendek et al. Jul 1999 A
5928201 Poulsen et al. Jul 1999 A
5938642 Burroughs et al. Aug 1999 A
5947934 Hansen et al. Sep 1999 A
5951530 Steengaard et al. Sep 1999 A
5954689 Poulsen Sep 1999 A
5957896 Bendek et al. Sep 1999 A
5961465 Kelly et al. Oct 1999 A
5961495 Walters et al. Oct 1999 A
5961496 Nielsen et al. Oct 1999 A
5980491 Hansen Nov 1999 A
5984900 Mikkelson Nov 1999 A
6001089 Burroughs et al. Dec 1999 A
6003736 Ljunggren Dec 1999 A
6004297 Steenfeldt-Jensen et al. Dec 1999 A
6010485 Buch-Rasmussen et al. Jan 2000 A
6033376 Rockley Mar 2000 A
6033377 Rasmussen et al. Mar 2000 A
6048336 Gabriel Apr 2000 A
6059755 Michel May 2000 A
6074372 Hansen Jun 2000 A
6083197 Umbaugh Jul 2000 A
6086567 Kirchhofer et al. Jul 2000 A
6096010 Walters et al. Aug 2000 A
6110149 Klitgaard et al. Aug 2000 A
6129080 Pitcher et al. Oct 2000 A
6146361 DiBiasi et al. Nov 2000 A
6193698 Kirchhofer et al. Feb 2001 B1
6221046 Burroughs Apr 2001 B1
6221053 Walters et al. Apr 2001 B1
6231540 Smedegaard May 2001 B1
6235004 Steenfeldt-Jensen et al. May 2001 B1
6248090 Jensen et al. Jun 2001 B1
6248095 Giambattista et al. Jun 2001 B1
6258062 Thielen et al. Jul 2001 B1
6269340 Ford et al. Jul 2001 B1
6277097 Mikkelsen et al. Aug 2001 B1
6277098 Klitmose et al. Aug 2001 B1
6277099 Strowe et al. Aug 2001 B1
6277101 Kirchhofer et al. Aug 2001 B1
6281225 Hearst et al. Aug 2001 B1
6283941 Schoenfeld et al. Sep 2001 B1
6302869 Klitgaard Oct 2001 B1
6287283 Ljunggreen et al. Nov 2001 B1
6312413 Jensen et al. Nov 2001 B1
6340357 Poulsen et al. Jan 2002 B1
6379399 Klitgaard et al. Apr 2002 B1
6383167 Kirchhofer et al. May 2002 B2
6428095 Hirata Aug 2002 B1
6454746 Bydlon et al. Sep 2002 B1
6514230 Munk et al. Feb 2003 B1
6547763 Steenfeldt-Jensen et al. Apr 2003 B2
6547764 Larsen et al. Apr 2003 B2
6562006 Hjertman et al. May 2003 B1
6562011 Buch-Rasmussen et al. May 2003 B1
6569126 Poulsen et al. May 2003 B1
6582404 Klitgaard et al. Jun 2003 B1
6605067 Larsen Aug 2003 B1
6613019 Munk Sep 2003 B2
6613023 Kirchhofer et al. Sep 2003 B2
6663602 Miller Dec 2003 B2
6692472 Hansen et al. Feb 2004 B2
6699224 Kirchhofer et al. Mar 2004 B2
6716198 Larsen Apr 2004 B2
6726661 Munk et al. Apr 2004 B2
6770288 Duirs Aug 2004 B2
6796970 Klitmose et al. Sep 2004 B1
6893415 Madsen et al. May 2005 B2
6899698 Sams May 2005 B2
6899699 Enggaard May 2005 B2
6921995 Nishimura et al. Jul 2005 B2
6923145 Wahl Aug 2005 B2
6932794 Giambattista et al. Aug 2005 B2
6936032 Bush, Jr. et al. Aug 2005 B1
6945961 Miller et al. Sep 2005 B2
7008399 Larsen et al. Mar 2006 B2
7090662 Wimpenny et al. Aug 2006 B2
7094221 Veasey et al. Aug 2006 B2
7104972 Moller et al. Sep 2006 B2
7133329 Skyggebjerg et al. Nov 2006 B2
D533575 Reawsanguanwong et al. Dec 2006 S
7169132 Bendek et al. Jan 2007 B2
7175055 Hansen et al. Feb 2007 B2
7195616 Diller et al. Mar 2007 B2
7241278 Moller Jul 2007 B2
7291132 DeRuntz et al. Nov 2007 B2
7316670 Graf et al. Jan 2008 B2
7361161 Bainton Apr 2008 B2
7553299 Veasey et al. Jun 2009 B2
7678084 Judson et al. Mar 2010 B2
7678085 Graf Mar 2010 B2
7736343 Marshall et al. Jun 2010 B2
7771400 Neilsen Aug 2010 B2
RE41956 Klitgaard et al. Nov 2010 E
7850662 Veasey et al. Dec 2010 B2
7905867 Veasey et al. Mar 2011 B2
7918833 Veasey et al. Apr 2011 B2
7935088 Veasey et al. May 2011 B2
8021345 Veasey et al. Sep 2011 B2
8070727 Veasey et al. Dec 2011 B2
8186233 Joung et al. May 2012 B2
8187233 Harms et al. May 2012 B2
8197450 Glejbol et al. Jun 2012 B2
8257319 Plumptre Sep 2012 B2
RE43834 Steenfeldt-Jensen et al. Nov 2012 E
8444606 Radmer et al. May 2013 B2
8512297 Veasey et al. Aug 2013 B2
8556864 Veasey et al. Oct 2013 B2
8603044 Veasey et al. Dec 2013 B2
8608709 Veasey et al. Dec 2013 B2
8663175 Veasey et al. Mar 2014 B2
8672896 Plumptre Mar 2014 B2
8679069 Veasey et al. Mar 2014 B2
8876782 Veasey et al. Nov 2014 B2
8888750 Veasey et al. Nov 2014 B2
8986260 Plumptre Mar 2015 B2
8992468 Martin et al. Mar 2015 B2
8992486 Veasey et al. Mar 2015 B2
9010051 Mackintosh Apr 2015 B2
9011391 Veasey et al. Apr 2015 B2
9022991 Moeller May 2015 B2
9028454 Veasey et al. May 2015 B2
9205197 Dette et al. Dec 2015 B2
9220845 Atterbury et al. Dec 2015 B2
9233211 Veasey et al. Jan 2016 B2
9408979 Veasey et al. Aug 2016 B2
9526844 Veasey et al. Dec 2016 B2
9533105 Veasey et al. Jan 2017 B2
9561331 Veasey et al. Feb 2017 B2
9604008 Veasey et al. Mar 2017 B2
9604009 Veasey et al. Apr 2017 B2
9610409 Veasey et al. Apr 2017 B2
9623189 Veasey et al. Apr 2017 B2
9623190 Veasey et al. Apr 2017 B2
9775954 Veasey et al. Oct 2017 B2
9827379 Veasey et al. Nov 2017 B2
10245383 Moller Apr 2019 B2
20010034507 Kirchhofer et al. Oct 2001 A1
20020007154 Hansen et al. Jan 2002 A1
20020052578 Moller May 2002 A1
20020053578 Iwamoto et al. May 2002 A1
20020077582 Mehdi et al. Jun 2002 A1
20020077852 Ford et al. Jun 2002 A1
20020120235 Enggaard Aug 2002 A1
20020165499 Slate et al. Nov 2002 A1
20030039679 Duirs Feb 2003 A1
20030050609 Sams Mar 2003 A1
20030172924 Staniforth et al. Sep 2003 A1
20040026728 Yoshida et al. Feb 2004 A1
20040059299 Moller et al. Mar 2004 A1
20040097883 Roe May 2004 A1
20040127858 Bendek et al. Jul 2004 A1
20040186431 Graf et al. Sep 2004 A1
20040210199 Atterbury et al. Oct 2004 A1
20040236282 Braithwaite Nov 2004 A1
20040249348 Wimpenny et al. Dec 2004 A1
20040260247 Veasey et al. Dec 2004 A1
20040267207 Veasey et al. Dec 2004 A1
20040267208 Veasey et al. Dec 2004 A1
20050004529 Veasey et al. Jan 2005 A1
20050019400 Deveney et al. Jan 2005 A1
20050033244 Veasey et al. Feb 2005 A1
20050055011 Enggaard Mar 2005 A1
20050113765 Veasey et al. May 2005 A1
20050205083 Staniforth et al. Sep 2005 A1
20050209570 Moller Sep 2005 A1
20050268915 Wassenaar et al. Dec 2005 A1
20060153693 Fiechter et al. Jul 2006 A1
20060206057 DeRuntz et al. Sep 2006 A1
20060264839 Veasey et al. Nov 2006 A1
20060276754 Kronestedt et al. Dec 2006 A1
20070016143 Miller et al. Jan 2007 A1
20070093761 Veasey et al. Apr 2007 A1
20070123829 Atterbury et al. May 2007 A1
20070233015 Saiki Oct 2007 A1
20070244436 Saiki Oct 2007 A1
20080188814 Lavi-Loebl et al. Aug 2008 A1
20090126294 Lovald et al. May 2009 A1
20090275915 Harms et al. Nov 2009 A1
20090275916 Harms et al. Nov 2009 A1
20100042054 Elahi et al. Feb 2010 A1
20100083608 Moller Apr 2010 A1
20110277394 Chich et al. Nov 2011 A1
20120053528 Bollenbach et al. Mar 2012 A1
20120110827 Doolittle et al. May 2012 A1
20120184917 Bom et al. Jul 2012 A1
20130245558 Holmqvist Sep 2013 A1
20150224266 Plumptre et al. Aug 2015 A1
20160045665 Bayer et al. Feb 2016 A1
20170340832 Veasey et al. Nov 2017 A1
20180036483 Veasey et al. Feb 2018 A1
20190240412 Veasey et al. Aug 2019 A1
Foreign Referenced Citations (68)
Number Date Country
2138528 Dec 1998 CA
2359375 Jul 2000 CA
2647230 Jun 2010 CA
3609555 Sep 1987 DE
10237258 Mar 2004 DE
0295075 Dec 1988 EP
0327910 Aug 1989 EP
0359070 Mar 1990 EP
0450905 Oct 1991 EP
0496141 Jul 1992 EP
0498737 Aug 1992 EP
0554996 Aug 1993 EP
0594349 Apr 1994 EP
0667469 Aug 1995 EP
0702970 Mar 1996 EP
0608343 Dec 1997 EP
0673482 Apr 1998 EP
0879610 Nov 1998 EP
0897729 Feb 1999 EP
0937471 Aug 1999 EP
0937476 Aug 1999 EP
0937477 Aug 1999 EP
1250167 Jul 2005 EP
1294418 Jul 2005 EP
1570876 Sep 2005 EP
1776975 Apr 2007 EP
1855743 Dec 2008 EP
2583291 Dec 1986 FR
2767479 Feb 1999 FR
0304822 Jan 1929 GB
0735433 Aug 1955 GB
0735443 Aug 1955 GB
1232899 May 1971 GB
2064012 Jun 1981 GB
2141799 Jan 1985 GB
2384431 Jul 2003 GB
05-337179 Dec 1993 JP
06-296691 Oct 1994 JP
H07500039 Jan 1995 JP
2111019 May 1998 RU
8907463 Aug 1989 WO
199009202 Aug 1990 WO
199110460 Jul 1991 WO
199114467 Oct 1991 WO
9307922 Apr 1993 WO
9324160 Dec 1993 WO
9419034 Sep 1994 WO
9625965 Aug 1996 WO
199626754 Sep 1996 WO
9638190 Dec 1996 WO
9736626 Oct 1997 WO
9810813 Mar 1998 WO
199857688 Dec 1998 WO
9856436 Dec 1998 WO
199916487 Apr 1999 WO
199938554 Aug 1999 WO
WO 9938554 Aug 1999 WO
200110484 Jul 2000 WO
0119434 Mar 2001 WO
2011051366 May 2001 WO
WO 2001051366 Jul 2001 WO
WO 0183008 Nov 2001 WO
0230495 Apr 2002 WO
02053214 Jul 2002 WO
02092153 Nov 2002 WO
WO 2002092153 Nov 2002 WO
03080160 Oct 2003 WO
2006084876 Aug 2006 WO
Non-Patent Literature Citations (32)
Entry
English Translation of Abstract of European Patent Application No. 0359070 dated Dec. 15, 2016.
Reissue U.S. Appl. No. 10/442,855, “Injection Syringe”, Filed May 21, 2003.
Reissue U.S. Appl. No. 10/960,900, “Injection Syringe”, Filed Oct. 7, 2004.
Reissue U.S. Appl. No. 11/121,331, “Injection Syringe”, Filed May 3, 2005.
Reissue U.S. Appl. No. 11/640,610, “Injection Syringe”, Filed Dec. 18, 2006.
First Office Action on merits dated Mar. 14, 2006 in U.S. Appl. No. 10/790,866 (11 pages).
“Pen-injectors for medical use—Part 1: Pen-injectors—Requirements and test methods,” International Standard, reference No. ISO 11608-1:2000(E), first edition Dec. 15, 2000, 32 pages.
U.S. Appl. No. 15/661,501, filed Jul. 27, 2017, Veasey et al..
U.S. Appl. No. 16/528,080, filed Jul. 31, 2019, Veasey et al..
“British Standard Specification for Spring Washers for General Engineering and Automobile Purposes—Metric Series,” British Standards Institution, BS 4464, May 19, 1969, 14 pages.
Deposition of Andreas Bode, Sanofi-Aventis U.S. LLC v. Mylan N.V., May 3, 2019 (excerpts concerning Novo FlexPen).
Deposition of David A. Plumptre, Sanofi-Aventis U.S. LLC v. Mylan N.V., Apr. 26, 2019 (excerpts).
A.G. Erdman & G.N. Sandor, “Mechanical Advantage”, §3.7 in 1 Mechanism Design: Analysis and Synthesis (1984).
Flexpen—Assembly study Presented by DCA Design International to Aventis as part of HM26 Stage 5 on Nov. 8, 2002, 5 pages.
Flexpen—Component details and proposed assembly sequence, 6 pages.
FlexPen—Novo Nordisk, 1 page.
Novo Nordisk A/S, Annual Financial Report 2003 obtained from https://www.marketscreener.com/NOVO-NORDISK-AS-1412980/pdf/9923/Novo%20Nordisk%20AS_Annual-Report.pdf.
Sclater et al., “Mechanisms & Mechanical Devices Sourcebook, Twenty Screw Devices” Third Edition, pp. 191-195, Jul. 2, 2001.
Opinion dated Mar. 9, 2020, Sanofi-Aventis U.S. LLC v. Mylan GmbH, United States District Court, District of New Jersey, Civil Action No. 17-9105 (SRC).
Mylan Pharmaceuticals Inc., v. Sanofi-Aventis Deutschland GmbH, “Preliminary Guidance Patent Owners Motion to Amend,” Case No. IPR2018-01679, U.S. Pat. No. 8,992,486 B2, entered Oct. 16, 2019, 11 pages.
Mylan Pharmaceuticals Inc., v. Sanofi-Aventis Deutschland GmbH, “Preliminary Guidance Patent Owner's Motion to Amend,” Case No. IPR2018-01680, U.S. Pat. No. 9,526,844 B2, entered Oct. 16, 2019, 11 pages.
Mylan Pharmaceuticals Inc., v. Sanofi-Aventis Deutschland GmbH, “Preliminary Guidance Patent Owner's Motion to Amend,” Case No. IPR2018-01682, U.S. Pat. No. 9,526,844, entered Oct. 16, 2019, 11 pages.
Mylan Pharmaceuticals Inc., v. Sanofi-Aventis Deutschland GmbH, “Final Written Decision Determining Sole Challenged Claim Unpatentable Denying Petitioner's Motion to Exclude,” Case No. IPR2018-01670, U.S. Pat. No. 8,679,069 B2, entered Apr. 2, 2020, 108 pages.
Mylan Pharmaceuticals Inc., v. Sanofi-Aventis Deutschland GmbH, “Final Written Decision Determining All Challenged Claims Unpatentable Denying Patent Owner's Motion to Amend Denying-in-Part, Dismissing-in-Part Petitioner's Motion to Exclude,” Case No. IPR2018-01679, U.S. Patent No. 8,992,486, entered May 29, 2020, 117 pages.
Mylan Pharmaceuticals Inc., v. Sanofi-Aventis Deutschland GmbH, “Final Written Decision Determining All Challenged Claims Unpatentable Denying Petitioner's Motion to Amend Denying Petitioner's Motion to Exclude,” Case No. IPR2018-01680, U.S. Pat. No. 9,526,844 B2, entered May 29, 2020, 131 pages.
Mylan Pharmaceuticals Inc., v. Sanofi-Aventis Deutschland GmbH, “Final Written Decision Determining All Challenged Claims Unpatentable Denying Petitioner's Motion to Amend Denying Petitioner's Motion to Exclude,” Case No. IPR2018-01682, U.S. Pat. No. 9,526,844 B2, entered May 29, 2020, 135 pages.
Mylan Pharmaceuticals Inc., v. Sanofi-Aventis Deutschland GmbH, “Final Written Decision Determining All Challenged Claims Unpatentable Denying Petitioner's Motion to Exclude,” Case No. IPR2018-00122, U.S. Patent No. 8,992,486 B2, entered May 29, 2020, 73 pages.
Mylan Pharmaceuticals Inc., v. Sanofi-Aventis Deutschland GmbH, “Final Written Decision Determining All Challenged Claims Unpatentable Denying Petitioner's Motion to Exclude,” Case No. IPR2018-01676, U.S. Patent No. 8,603,044 B2, entered May 29, 2020, 59 pages.
Mylan Pharmaceuticals Inc., v. Sanofi-Aventis Deutschland GmbH, “Final Written Decision Determining Claims 1, 7, 8, and 17 are Unpatentable Denying Petitioner's Motion to Exclude,” Case No. IPR2018-01684, U.S. Pat. No. 9,604,008 B2, entered May 29, 2020, 67 pages.
Mylan Pharmaceuticals Inc., v. Sanofi-Aventis Deutschland GmbH, “Final Written Decision Determining All Challenged Claims Unpatentable Denying Petitioner's Motion to Exclude,” Case No. IPR2018-01675, U.S. Pat. No. 8,603,044 B2, entered May 29, 2020, 66 pages.
Pfizer Inc., v. Sanofi-Aventis Deutschland GmbH, “Final Written Decision Determining All Challenged Claims Unpatentable Denying Petitioner's Motion to Exclude,” Case No. IPR2019-00979, U.S. Pat. No. 8,679,069, entered Aug. 11, 2020, 108 pages.
U.S. 3rd Party Submission under 37 CFR in U.S. Appl. No. 16/848,543, dated Apr. 15, 2021, 10 pages.
Related Publications (1)
Number Date Country
20170340832 A1 Nov 2017 US
Divisions (1)
Number Date Country
Parent 13040198 Mar 2011 US
Child 13919251 US
Continuations (6)
Number Date Country
Parent 15180141 Jun 2016 US
Child 15681604 US
Parent 14946203 Nov 2015 US
Child 15180141 US
Parent 14635573 Mar 2015 US
Child 14946203 US
Parent 13919251 Jun 2013 US
Child 14635573 US
Parent 11483546 Jul 2006 US
Child 13040198 US
Parent 10790225 Mar 2004 US
Child 11483546 US